Concepedia

Publication | Open Access

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

DOIFull Paper Access

17

Citations

36

References

2023

Year

Shuochen Liu, Shilong Fan, Yirui Wang, Ruixiang Chen, Ziyi Wang, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Yue Yu,
BMC Cancer

Abstract

The current findings demonstrated ACSL4 may as a novel biomarker for CHOL patients, which might regulate immune microenvironment and metabolism resulting in poor prognosis.

References

YearCitations

Page 1